IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,806 | +1138.7% | 125,212 | +510.6% | 0.00% | – |
| Q2 2023 | $388 | +58.4% | 20,506 | +29.3% | 0.00% | – |
| Q1 2023 | $245 | +63.3% | 15,854 | +86.7% | 0.00% | – |
| Q4 2022 | $150 | -99.7% | 8,492 | -11.3% | 0.00% | – |
| Q3 2022 | $53,000 | – | 9,577 | +17312.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 55 | -98.6% | 0.00% | – |
| Q4 2021 | $34,000 | -72.1% | 4,019 | -62.8% | 0.00% | – |
| Q3 2021 | $122,000 | +159.6% | 10,800 | +139.8% | 0.00% | – |
| Q2 2021 | $47,000 | – | 4,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |